Main Article Content
Despite the improvement of diagnostic and therapeutic techniques age-related macular degeneration is still one of the main causes of central vision impairment.
Throughout the years, the classification of subretinal neovascularization in the course of age-related macular degeneration has changed due to the advancement of diagnostic and therapeutic techniques. In 2020 an expert panel reached consensus on a new nomenclature for neovascularization in the course of age-related macular degeneration introducing the concept of macular neovascularization, which refers to each neovascularization in macula, regardless of the location.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (firstname.lastname@example.org)
2. Spaide RF, Jaffe GJ, Sarraf D et al. Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. Ophthalmology [Internet]. 2020; 127(5): 616-36.
3. Laiginhas R, Yang J, Philip JR et al. Nonexudative Macular Neovascularization – A Systematic Review of Prevalence, Natural History, and Recent Insights from OCT Angiography. Ophthalmology Retina. 2020; 4(7): 651-61. https://doi.org/10.1016/j.oret.2020.02.016.
4. Al-Sheikh M, Iafe NA, Phasukkijwatana N et al. Biomarkers of Neovascular Activity in Age-Related Macular Degeneration Using Oct Angiography. Retina. 2018; 38(2): 220-30. https://doi.org/10.1097/IAE.0000000000001628.
5. El Ameen A, Cohen SY, Semoun O. Type 2 neovascularization secondary to age-related macular degeneration imaged by optical coherence tomography angiography. Retina. 2015; 35(11): 2212-8. http://doi.org/10.1097/IAE.0000000000000773.
6. Kunho B, Hyo JK, Yong KS et al. Predictors of neovascular activity during neovascular age-related macular degeneration treatment based on optical coherence tomography angiography. Sci Rep. 2019; 9(1): 19240. http://doi.org/10.1038/s41598-019-55871-8.
7. Souied EH, El Ameen A, Semoun O. Optical Coherence Tomography Angiography of Type 2 Neovascularization in Age-Related Macular Degeneration. Dev Ophthalmol. 2016; 56: 52-6. http://doi.org/10.1159/000442777.
8. Freund KB, Zweifel SA, Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina. 2010; 30(9): 1333-49. http://doi.org/10.1097/IAE.0b013e3181e7976b. Erratum in: Retina. 2011; 31(1): 208.
9. Bandello F, Souied EH, Querques G (ed). OCT Angiography in Retinal and Macular Diseases. Optical Coherence Tomography Angiography of Type 3 Neovascularization. Dev Ophthalmol. 2016; 56: 57-61. http://doi.org/10.1159/000442779.
10. Yonekawa Y, Kim I. Clinical Characteristics and Current Treatment of Age-Related Macular Degeneration. Cold Spring Harb Perspec Med. 2014; 5(1): a017178. http://doi.org/10.1101/cshperspect.a017178.
11. Cheung CMG, Lai TYY, Ruamviboonsuk P et al. Polypoidal Choroidal Vasculopathy Definition, Pathogenesis, Diagnosis, and Management. Ophthalmology. 2018; 125(5): 708-24.
12. Yannuzzi LA, Sorenson J, Spaide RF et al. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina. 1990; 10(1): 1-8.
13. Opala A, Terelak-Borys B, Grabska-Liberek I. Polypoidal choroidal vasculopathy. Klinika Oczna / Acta Ophthalmologica Polonica. 2019; 121(2): 112-7. http://doi.org/10.5114/ko.2019.86954.